Hervé Boutin Selected Research

PK 11195 (PK11195)

12/2021	TSPO imaging in animal models of brain diseases.
1/2013	[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats.
5/2010	In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C]PK11195 in an acute rodent model.
12/2008	Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.
11/2007	In vivo imaging of brain lesions with [(11)C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors.
4/2007	11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hervé Boutin Research Topics

Disease

14	Neuroinflammatory Diseases 12/2021 - 04/2007
4	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 07/2017
4	Stroke (Strokes) 12/2021 - 11/2007
3	Inflammation (Inflammations) 01/2017 - 05/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 04/2007
2	Brain Diseases (Brain Disorder) 01/2013 - 12/2008
2	Brain Ischemia (Cerebral Ischemia) 01/2013 - 06/2003
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2007 - 06/2003
1	Dehydration (Water Stress) 03/2022
1	Gliosis 01/2020
1	Cognitive Dysfunction 01/2020
1	Mucopolysaccharidoses 01/2020
1	Infections 01/2018
1	Dementia (Dementias) 01/2018
1	Amyloid Plaque 01/2018
1	Pathologic Processes 01/2017
1	Nervous System Diseases (Neurological Disorders) 05/2010
1	Infarction (Infarctions) 11/2007

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2008
6	PK 11195 (PK11195)IBA 12/2021 - 04/2007
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2007
5	GABA-A Receptors (GABA(A) Receptor)IBA 05/2010 - 04/2007
4	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 12/2021 - 12/2008
3	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2021 - 01/2013
3	LigandsIBA 01/2013 - 04/2007
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020 - 11/2010
2	Pharmaceutical PreparationsIBA 01/2018 - 12/2008
2	2- (6- chloro- 2- (4- iodophenyl)- imidazo(1,2- alpha)pyridin- 3- yl)- N- ethyl- N- methyl- acetamideIBA 05/2010 - 11/2007
2	acetamideIBA 03/2009 - 04/2007
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 11/2007 - 06/2003
2	Opioid Receptors (Opioid Receptor)IBA 11/2007 - 06/2003
1	Amyloid (Amyloid Fibrils)IBA 03/2022
1	Ethanol (Ethyl Alcohol)IBA 03/2022
1	PrionsIBA 03/2022
1	LipopolysaccharidesIBA 12/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	Cholinergic ReceptorsIBA 01/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	InflammasomesIBA 01/2020
1	Amyloid beta-PeptidesIBA 01/2020
1	Ion Channels (Ion Channel)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	NeurograninIBA 07/2017
1	C-Reactive ProteinIBA 08/2011
1	LipidsIBA 08/2011
1	indoleacetamideIBA 03/2011
1	SSR180575IBA 03/2011
1	N,N- diethyl- 2- (2- (4- methoxyphenyl)- 5,7- dimethyl- pyrazolo(1,5- a)pyrimidin- 3- yl)- acetamideIBA 04/2007

Therapy/Procedure

2	Therapeutics 01/2017 - 12/2008